ST. Charles Pharmaceuticals

New Orleans, LA 70130

SBIR Award Summary

Total Number of Awards 17
Total Value of Awards $3.9MM
First Award Date 09/10/00
Most Recent Award Date 09/01/10

Key Personnel

Last Name Name Awards Contact
Narducy Kenneth W Narducy 13
Vaccarino Anthony L Vaccarino 4

17 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-06-005
Budget: 09/01/10 - 08/31/12

DESCRIPTION (provided by applicant): Chronically, medically resistant pain is one of the most significant health problems in our country and affects more than 50 million Americans. Neuropathic pain syndromes are for the most part resistant to traditional analgesic treatments with NSAIDs, acetaminophen, or opiate medications (eg, morphine, codei...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-06-005
Budget: 09/30/07 - 05/31/08

Project Summary / Abstract Chronically, medically resistant pain is one of the most significant health problems in our country and affects more than 50 million Americans. Neuropathic pain syndromes are for the most part resistant to traditional analgesic treatments with NSAIDs, acetaminophen, or opiate medications (eg, morphine, codeine). Furthe...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-06-005
Budget: 09/30/07 - 05/31/08

Project Summary / Abstract Chronically, medically resistant pain is one of the most significant health problems in our country and affects more than 50 million Americans. Neuropathic pain syndromes are for the most part resistant to traditional analgesic treatments with NSAIDs, acetaminophen, or opiate medications (eg, morphine, codeine). Furthe...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-06-005
Budget: 09/30/07 - 08/31/09

DESCRIPTION (provided by applicant): Chronically, medically resistant pain is one of the most significant health problems in our country and affects more than 50 million Americans. Neuropathic pain syndromes are for the most part resistant to traditional analgesic treatments with NSAIDs, acetaminophen, or opiate medications (eg, morphine, codei...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-06
Budget: 03/06/07 - 03/05/08

DESCRIPTION (provided by applicant): Intravenous drug administration is often clinically desired over oral administration, particularly for patients who have difficulty taking an oral drug due to their disease or condition (eg, unconsciousness, anesthetized). IV administration also produces a faster therapeutic onset and permits more accurate do...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 12/01/06 - 11/30/07

The therapeutic use of some analgesic compounds are often limited because of potentially adverse and dangerous side-effects. However, combinations of analgesics with different mechanisms of action could enhance analgesic efficacy (synergy) while reducing the dose-dependent adverse effects of the individual components. The development of combinat...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/15/05 - 11/30/06

DESCRIPTION (provided by applicant): The therapeutic use of some analgesic compounds is often limited because of potentially adverse and dangerous side effects. However, combinations of analgesics with different mechanisms of action could enhance analgesic efficacy (synergy) while reducing the dose-dependent adverse effects of the individual com...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/23/04 - 08/22/05

DESCRIPTION (provided by applicant): Pain is the most prevalent symptom in cancer patients, and bone metastasis is one of the most common sources of cancer-related pain. In the 3-step guidelines established by the World Health Organization (WHO) non-opioid analgesics (acetaminophen and NSAIDs) are the first step against cancer pain. In step 2, w...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/04 - 08/31/05

DESCRIPTION (provided by applicant): Acetaminophen is widely used for treatment of pain and/or fever in the elderly. This dual action is sometimes contraindicated. In many instances, pain needs to be controlled without masking the symptomatic fever (e.g., fever due to infection during the postoperative period). Acetaminophen can also cause hepat...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/03 - 08/31/04

DESCRIPTION (provided by applicant): Acetaminophen is widely used for treatment of pain and/or fever in the elderly. This dual action is sometimes contraindicated. In many instances, pain needs to be controlled without masking the symptomatic fever (e.g., fever due to infection during the postoperative period). Acetaminophen can also cause hepat...

Load More